CGS 10746B

selectively decreases dopamine release; structure given in first source

Also Known As:

5-(4-methyl-1-piperazinyl)imidazo(2,1-b)(1,3,5)benzothiadiazepine maleate; CGS-10746-B; CGS-10746B

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Tremor (Tremors) 06/01/2003 - "The results show that dopamine seems to be necessary for the development of conditioned somatic signs of morphine withdrawal, as animals which received CGS 10746B do not present paw tremor or body shakes when they are placed in the environment paired with two previously induced withdrawals. "